Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2025-12-25 @ 4:29 PM
NCT ID: NCT04707157
Description: All enrolled participants who took at least 1 dose of study drug.
Frequency Threshold: 3
Time Frame: Baseline through Week 8
Study: NCT04707157
Study Brief: Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
600 mg LY3556050 Participants received 600 mg LY3556050 BID every 12 hours for up to 8 weeks. 0 None 2 45 30 45 View
Placebo Participants received placebo BID every 12 hours for up to 8 weeks. 0 None 2 23 16 23 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Osteomyelitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Overdose SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 25.0 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 25.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.0 View
Palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 25.0 View
Thyroiditis subacute SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA 25.0 View
Abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Abdominal pain lower SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Abdominal pain upper SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.0 View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.0 View
Cholelithiasis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA 25.0 View
Covid-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Sinusitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Anion gap increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 25.0 View
Blood creatinine increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 25.0 View
Blood gastrin increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 25.0 View
Blood insulin increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 25.0 View
Cystatin c increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 25.0 View
Glomerular filtration rate decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 25.0 View
Hyperglycaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 25.0 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 25.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.0 View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.0 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 25.0 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 25.0 View